drug-eluting stent
Prognostic Analysis of Drug-Eluting Balloon Catheter and Drug-Eluting Stent for In-Stent Restenosis of Drug-Eluting Stent
... Keywords: Drug-eluting balloon, Drug-eluting stent, In-stent restenosis, Major adverse cardiac events Ⅰ . INTRODUCTION 스텐트 재협착(Restenosis)이란 경피적 관상 동맥 중재술(PCI; Percutaneous ...
9
Stent Thrombosis in the Era of the Drug-Eluting Stent
... as stent material, design, surface coating, and adjunctive therapeutic agents, such as radiation or drugs, were suggested as risk ...total stent length and the use of multiple stents per lesion may be ...
4
Very Late Thrombosis of a Drug-Eluting Stent After
... a Drug-Eluting Stent After Discontinuation of Dual Antiplatelet Therapy in a Patient Treated With Both Drug-Eluting and Bare-Metal Stents Sung Soo Kim, MD 1 , Myung Ho Jeong, MD 1,2 , ...
4
Development of Evaluation Method for Drug Release Propreties in Drug Eluting Stent
... 약물방출스텐트의 약물 방출 특성 평가 방법 개발 송정민·백홍·이승영·장동혁·서무엽·박길종·맹은호 한국화학융합시험연구원 의료기기본부 의료용품팀 Development of Evaluation Method for Drug Release Propreties in Drug Eluting Stent ...
4
Comparison of Drug-Eluting Balloon Followed by Bare Metal Stent with Drug-Eluting Stent for Treatment of de Novo Lesions: Randomized, Controlled, Single-Center Clinical Trial
... Keywords: Drug-eluting Balloon; Bare Metal Stent; Drug-eluting Stent; In-segment Late Loss; Coronary Artery Disease In-Ho Chae, Chang-Hwan Yoon, Jin Joo Park, Il-Young Oh, ...
9
Severe Acute Stent Malapposition After Drug-Eluting Stent Implantation: Effects on Long-Term Clinical Outcomes
... acute stent malapposition (ASM) after drug-eluting stent implantation on long-term clinical outcomes are not clearly ...follow-up drug-eluting stent strut coverage and one ...
11
Therapeutic Strategy for In-Stent Restenosis Based on the Restenosis Pattern After Drug-Eluting Stent Implantation
... After Drug-Eluting Stent Implantation Ki-Hun Kim, MD 1 , Doo-Il Kim, MD 1 , Il-Hwan Kim, MD 1 , Jong-Yoon Kim, MD 1 , Yang-Chun Han, MD 1 , Sang-Hoon Seol, MD 1 , Ung Kim, MD 1 , Tae-Hyun Yang, MD 1 ...
6
Impact of statin treatment on strut coverage after drug-eluting stent implantation
... after drug- eluting stent (DES) ...sirolimus-eluting stent (SES) or biolim- us-eluting stent (BES) implantation, after which patients were randomly treated with ...
8
Impact of statin treatment on strut coverage after drug-eluting stent implantation
... over stent struts has been emerged as a clinical issue since it was reported that incomplete strut coverage might be associated with occurrence of late stent thrombosis following drug-eluting ...
30
Efficacy and safety of antiplatelet-combination therapy after drug-eluting stent implantation
... after drug-eluting stent implantation Yun-Kyeong Cho 1 , Chang-Wook Nam 1 , Hyoung-Seob Park 1 , Hyuck-Jun Yoon 1 , Hyungseop Kim 1 , Seung-Ho Hur 1 , Yoon-Nyun Kim 1 , Jang-Hoon Lee 2 , Dong-Heon ...
7
Randomized Comparison of Cilostazol vs Clopidogrel After Drug-Eluting Stenting in Diabetic Patients - CIilostazol for Diabetic Patients in Drug-Eluting Stent (CIDES) Trial -
... prevent stent thrombosis, but may also have positive effect in the prevention of ...of drug-eluting stent (DES) in patients with diabetes mellitus has not been ...subacute stent ...
5
Two-year Clinical Outcomes Following Everolimus-eluting Stent Use for Off-label Versus On-label Indications: From the Korean Multicenter Drug-eluting Stent Registry
... disease, Drug-eluting stents, Off-label use Introduction Since the Food and Drug Administration approval of the use of the first drug-eluting stent (DES) in April 2003, DES has ...
12
Optimal Duration of Dual Antiplatelet Therapy After Drug-Eluting Stent Implantation A Randomized, Controlled Trial
... after drug-eluting stent implantation unless patients are at high risk for ...received drug-eluting ...after drug-eluting stent implantation is not ...
29
Off-pump Coronary Artery Bypass Surgery Versus Drug Eluting Stent for Multi-vessel Coronary Artery Disease
... ＜0.001 OPCAB=Off-Pump Coronary Artery Bypass; DES=Drug Eluting Stent; MACE=Major adverse cardiac event (Death, Myocardial infarct, Target vessel revascularization). 행 1개월 째, 표적혈관 재개통율의 차이는 양측 모두 관찰 ...
8
Clinical outcomes of prolonged dual antiplatelet therapy after coronary drug-eluting stent implantation in dialysis patients
... Correspondence to: Dong Ki Kim; E-mail: dkkim73@gmail.com ABSTRACT Background. End-stage renal disease yields susceptibility to both ischemia and bleeding. The optimal duration of dual antiplatelet therapy (DAPT) after ...
10
Drug-Eluting Stent Thrombosis During Perioperative Period
... at least 2 weeks, and ideally 4 to 6 weeks, to allow for at least partial endotheliza- tion of the stent. 16) However, data for patients with DES is not well established. DES contain an antiproliferative agent ...
8
Coronary Stent Thrombosis: Current Insights into New Drug-Eluting Stent Designs
... after stent implantation leads to the pro- liferation and migration of vascular smooth muscle cells through the cell cycle pathway, which results in the devel- opment of neointimal hyperplasia and in-stent ...
9
Long-term Clinical Outcomes of Drug-Eluting Stent Malapposition
... the stent to the vessel wall is less than 350–400 ...distances, stent-wall recirculation zones, highly thrombogenic areas around struts, first grew in size, shifted down-stream, and then lost stent ...
10
Predictive Factors for Restenosis after Drug-Eluting Stent Implantation
... Diabetic patients are generally prone to restenosis after percutaneous coronary intervention, but there are conflicting findings regarding the impact of diabetes mellitus on restenosis after DES implantation. The post- ...
6
Aspirin and Clopidogrel Resistance in Drug Eluting Stent Era
... Despite its proven benefit, the responses of individual patients show considerable heterogeneity to aspirin and to clopidogrel. 8 - 11) The recent data shows that adequate antiplatelet effects are not achieved in 5% to ...
13